Exhibit 107

Calculation of Filing Fee Tables

Form F-3

(Form Type)

Connect Biopharma Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Fees to be paid

Equity

Ordinary shares, par value US$0.000174 per share (1)

Rule 457(o)

(2)(3)(4)

(5)

$300,000,000

.0000927

US$27,810.00

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$300,000,000

$27,810.00

Total Fees Previously Paid

N/A

Total Fee Offsets

N/A

Net Fee Due

$27,810

(1) These ordinary shares will be represented by American Depositary Shares, or ADSs, each of which represents one ordinary share of the registrant. ADSs issuable on deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-254215).

(2) The securities registered hereunder include such indeterminate number of ordinary shares represented by ADSs, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of ordinary shares represented by ADSs as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.

(3) Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any stock splits, stock dividend or similar transaction.

(4) Includes rights to acquire ordinary shares represented by ADSs of the registrant under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(5) The proposed maximum offering price per ordinary share represented by an ADS will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder.